SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-009648
Filing Date
2020-08-06
Accepted
2020-08-06 16:10:01
Documents
14
Period of Report
2020-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20200805x8k.htm   iXBRL 8-K 42687
2 EX-99.1 edit-20200805xex99d1.htm EX-99.1 83879
3 GRAPHIC edit-20200805xex99d1001.jpg GRAPHIC 4323
  Complete submission text file 0001558370-20-009648.txt   263911

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20200805.xsd EX-101.SCH 3050
5 EX-101.LAB edit-20200805_lab.xml EX-101.LAB 15382
6 EX-101.PRE edit-20200805_pre.xml EX-101.PRE 9973
7 EXTRACTED XBRL INSTANCE DOCUMENT edit-20200805x8k_htm.xml XML 4632
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 201081680
SIC: 2836 Biological Products, (No Diagnostic Substances)